Monday, 28 September 2015

Erythropoietin Market in Japan 2015-2019

Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein that is responsible for the production of erythrocytes in the body. In the fetal stage, this protein is produced in the liver. However, in adulthood it is produced in the kidneys. During anemic conditions, the body produces an excess of erythropoietin to maintain a normal level of red blood cells. When the endogenous production of erythropoietin is disrupted because of illness or medications, normal red blood cell levels are maintained by an injecting erythropoiesis-stimulating agents (ESAs). These agents are similar to natural erythropoietin in structure and function. They can be produced by recombinant DNA technology and are used in the treatment of anemia resulting from renal disease, cancer, HIV, injuries, or neurological conditions.

Technavio's analysts forecast the erythropoietin market in Japan to decline at a CAGR of (1.16) % over the period 2014-2019.

Covered in this Report
In this report, Technavio covers the present scenario and growth prospects of the erythropoietin market in Japan for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of erythropoietin drugs and biosimilars used in the treatment of anemia due to renal disease, chemotherapy, antiretroviral therapy, wounds, or neurological conditions.

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
 What are the key market trends?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the market opportunities and threats faced by the key vendors?
 What are the strengths and weaknesses of the key vendors?

Table Of Content

PART 01: Executive summary

PART 02: Scope of  the report
 Market overview
 Top-vendor offerings

PART 03: Market research methodology
 Research methodology
 Economic indicators

PART 04: Introduction
 Key market highlights

PART 05: Biosimilars and biologics industry
 Emerging role of biosimilars
 Factors influencing biosimilars and biologics industry
 Biosimilars: Business and pricing strategy
 Biosimilars industry: Viewpoints of providers, payers, buyers, vendors, and regulatory bodies

PART 06: Japan: Country snapshot
 Pharmaceutical industry in Japan
 Biosimilars and biologics industry in Japan
 Regulatory landscape
 Healthcare reforms
 Erythropoietin: Addressable market in Japan

PART 07: Global erythropoietin drugs market

PART 08: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis

PART 09: Market segmentation by application
 End-stage renal disease
 Wounds and neural disease

PART 10: Market segmentation by product
 First-generation erythropoietin formulation
 Second-generation erythropoietin formulation

Request A Sample copy of This Report @

PART 11: Market segmentation by end-user

PART 12: Market drivers
 Increased incidence of anemia
 Reimbursement for erythropoietin preparations
 Favorable growth opportunities

PART 13: Impact of drivers

PART 14: Market challenges
 Complex manufacturing process
 Complicated regulatory framework
 Physician's reluctance to prescribe biosimilars

PART 15: Impact of drivers and challenges

PART 16: Market trends
 Strategic alliances
 Increased R&D of innovative molecule drugs
 Focus on biosimilars

PART 17: Vendor landscape
 Competitive scenario
 Market share analysis 2014

PART 18: Key vendor analysis
 Chugai Pharmaceutical
 JCR Pharmaceuticals
 Kissei Pharmaceutical
 Kyowa Hakko Kirin

PART 19: Appendix
 List of abbreviations

PART 20: Explore Technavio

About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number

No comments:

Post a Comment